Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA   US9216591084

Delayed Quote. Delayed Nasdaq - 07/23 04:00:01 pm
14.06 USD   +5.56%
15h ago VANDA PHARMACEUTICALS : Assigned Patent
6d ago VANDA PHARMACEUTICALS : to Announce Second Quarter 2014 Financial Results o..
6d ago VANDA PHARMACEUTICALS : Other Events (form 8-K)
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/17/2014 07/18/2014 07/21/2014 07/22/2014 07/23/2014 Date
12.87(c) 13.32(c) 13.13(c) 13.32(c) 14.06(c) Last
612 381 403 985 332 300 227 969 435 120 Volume
-2.28% +3.50% -1.43% +1.45% +5.56% Change
More quotes
Company
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. Its product portfolio includes Fanapt and Tasimelteon. The Fanapt product is a compound for the treatment of schizophrenia,... 
Surperformance© rating of Vanda Pharmaceuticals Inc.
Trading Rating : Investor Rating :
More about the company
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 45,4 M
EBIT 2014 -77,4 M
Net income 2014 -83,2 M
Debt 2014 -
Yield 2014 -
Sales 2015 99,2 M
EBIT 2015 -24,4 M
Net income 2015 -38,8 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 9,80x
Capi. / Sales 2015 4,48x
Capitalization 445 M
More Financials
Latest news on VANDA PHARMACEUTICALS INC.
15h ago VANDA PHARMACEUTICALS : Assigned Patent
6d ago VANDA PHARMACEUTICALS : to Announce Second Quarter 2014 Financial Results on Aug..
6d ago VANDA PHARMACEUTICALS : Other Events (form 8-K)
06/16 VANDA PHARMACEUTICALS : Other Events (form 8-K)
06/12 VANDA PHARMACEUTICALS : European Medicines Agency Accepts HETLIOZ™ tasimel..
06/10 VANDA PHARMACEUTICALS : Other Events (form 8-K)
06/04 WEDNESDAY'S ETF MOVERS : Xbi, gxc
06/04 VANDA PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Exhib..
06/03 VANDA PHARMACEUTICALS : European Medicines Agency Accepts HETLIOZ™ (tasime..
06/03 VANDA PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8-..
06/03 VANDA PHARMACEUTICALS : European Medicines Agency Accepts HETLIOZ(TM) (tasimelte..
06/02 VANDA PHARMACEUTICALS : HETLIOZ™ (tasimelteon) Data in Patients with Non-2..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
Vanda Pharmaceuticals Inc. : Income Statement Evolution
More Financials
EPS Revisions
Vanda Pharmaceuticals Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF